The following products are protected by U.S. patents as indicated below. This website is provided to satisfy the virtual patent marking provisions of 35 U.S.C. § 287(a). The following list of products may not be all inclusive, and other products not listed here may be protected by one or more US patents and patents pending.

PRODUCT PATENT NO.
APRISO® (mesalamine) extended -release capsules 8865688
COLAZAL® (balsalazide disodium) capsules 7452872
7625884
CYCLOSET® (bromocriptine mesylate) tablets 7888310
8137992
8137993
8137994
8431155
8613947
9192576
9522117
9700555
9993474
8877708
9352025
9895422
9993474
10688094
10688155
11000522
FENOGLIDE® (fenofibrate) tablets 7658944
8124125
8481078
9173847
GLUMETZA® (metformin hydrochloride) extended release tablets - 1000 mg 7780987
MOVIPREP® (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution) 7169381
7658914
OSMOPREP® (sodium phosphate monobasic monohydrate and sodium phostphate dibasic anhydrous) tablets 7687075
PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride for oral solution) 8999313
9326969
9592252
9707297
10016504
10646512
10780112
10792306
10918723
11529368
RELISTOR® (methylnaltrexone bromide) tablets 8420663
8524276
8956651
9180125
9314461
9492445
9724343
10307417
10376505
RELISTOR® (methylnaltrexone bromide) injection 8247425
8420663
8822490
9180125
9492445
TRULANCE® (plecanatide) tablets 7041786
9610321
9616097
9919024
9925231
10011637
11142549
11319346
11834521
UCERIS® (budesonide) extended release tablets 8895064
9132093
9192581
10307375
10660858
XIFAXAN® (rifaximin) tablets - 200 mg 7906542
7928115
8193196
8518949
8741904
8835452
9271968
10703763
XIFAXAN® (rifaximin) tablets - 550 mg 7906542
7915275
8193196
8309569
8518949
8642573
8741904
8829017
8835452
8946252
8969398
9271968
9421195
9629828
10314828
10335397
10456384
10703763
10709694
10765667
11564912
11779571